A citation-based method for searching scientific literature

Taiji Tsunemi, Kinya Ishikawa, Kei Tsukui, Takuro Sumi, Ken Kitamura, Hidehiro Mizusawa. J Neurol Sci 2010
Times Cited: 21







List of co-cited articles
230 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
115
52

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
M Strupp, O Schüler, S Krafczyk, K Jahn, F Schautzer, U Büttner, T Brandt. Neurology 2003
156
47

Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
M Strupp, R Kalla, M Dichgans, T Freilinger, S Glasauer, T Brandt. Neurology 2004
149
47

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
115
47

Aminopyridines for the treatment of cerebellar and ocular motor disorders.
Michael Strupp, Roger Kalla, Stefan Glasauer, Judith Wagner, Katharina Hüfner, Klaus Jahn, Thomas Brandt. Prog Brain Res 2008
38
38

4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Roger Kalla, Stefan Glasauer, Ulrich Büttner, Thomas Brandt, Michael Strupp. Brain 2007
78
38

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
106
38

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
T A Zesiewicz, P E Greenstein, K L Sullivan, L Wecker, A Miller, I Jahan, R Chen, S L Perlman. Neurology 2012
71
38


Clinical spectrum of episodic ataxia type 2.
J Jen, G W Kim, R W Baloh. Neurology 2004
183
33

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.
R A Ophoff, G M Terwindt, M N Vergouwe, R van Eijk, P J Oefner, S M Hoffman, J E Lamerdin, H W Mohrenweiser, D E Bulman, M Ferrari,[...]. Cell 1996
28

Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering.
Catherine J C Weisz, Robert S Raike, Luis E Soria-Jasso, Ellen J Hess. J Neurosci 2005
48
28

Effects of ablation of flocculus and paraflocculus of eye movements in primate.
D S Zee, A Yamazaki, P H Butler, G Gücer. J Neurophysiol 1981
658
28

Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Roger Kalla, Rainer Spiegel, Jens Claassen, Stanislavs Bardins, Ales Hahn, Erich Schneider, Nicole Rettinger, Stefan Glasauer, Thomas Brandt, Michael Strupp. J Neuroophthalmol 2011
30
28

Intensive coordinative training improves motor performance in degenerative cerebellar disease.
W Ilg, M Synofzik, D Brötz, S Burkard, M A Giese, L Schöls. Neurology 2009
153
28

4-aminopyridine and cerebellar gait: a retrospective case series.
Roman Schniepp, Max Wuehr, Maximilian Neuhaeusser, Ann Kathrin Benecke, Christine Adrion, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2012
42
28

Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial.
Luis Velázquez-Pérez, Jorge Rodríguez-Chanfrau, Julio Cesar García-Rodríguez, Gilberto Sánchez-Cruz, Raúl Aguilera-Rodríguez, Roberto Rodríguez-Labrada, Julio Cesar Rodríguez-Díaz, Nalia Canales-Ochoa, Dennis Almaguer Gotay, Luis E Almaguer Mederos,[...]. Neurochem Res 2011
21
28

Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.
Ichiro Miyai, Mizuki Ito, Noriaki Hattori, Masahito Mihara, Megumi Hatakenaka, Hajime Yagura, Gen Sobue, Masatoyo Nishizawa. Neurorehabil Neural Repair 2012
106
28

Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry.
I Yabe, H Sasaki, I Yamashita, A Takei, K Tashiro. Acta Neurol Scand 2001
46
28

Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series.
Michael Strupp, Julian Teufel, Maximilian Habs, Regina Feuerecker, Carolin Muth, Bart P van de Warrenburg, Thomas Klopstock, Katharina Feil. J Neurol 2013
51
28

Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
95
28

4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
S Glasauer, R Kalla, U Büttner, M Strupp, T Brandt. J Neurol Neurosurg Psychiatry 2005
57
23

18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
Sandra Bense, Christoph Best, Hans-Georg Buchholz, Valerie Wiener, Mathias Schreckenberger, Peter Bartenstein, Marianne Dieterich. Neuroreport 2006
36
23

Detection of floccular hypometabolism in downbeat nystagmus by fMRI.
R Kalla, A Deutschlander, K Hufner, T Stephan, K Jahn, S Glasauer, T Brandt, M Strupp. Neurology 2006
62
23

Hereditary paroxysmal ataxia: response to acetazolamide.
R C Griggs, R T Moxley, R A Lafrance, J McQuillen. Neurology 1978
160
23

Downbeat nystagmus: aetiology and comorbidity in 117 patients.
J N Wagner, M Glaser, T Brandt, M Strupp. J Neurol Neurosurg Psychiatry 2008
97
23

Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
Jens Claassen, Julian Teufel, Roger Kalla, Rainer Spiegel, Michael Strupp. J Neurol 2013
21
23

Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Raphael Hourez, Laurent Servais, David Orduz, David Gall, Isabelle Millard, Alban de Kerchove d'Exaerde, Guy Cheron, Harry T Orr, Massimo Pandolfo, Serge N Schiffmann. J Neurosci 2011
88
23

Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.
M I Botez, T Botez-Marquard, R Elie, O L Pedraza, K Goyette, R Lalonde. J Neurol Neurosurg Psychiatry 1996
63
23

Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity.
Aasef G Shaikh, Simon Hong, Ke Liao, Jing Tian, David Solomon, David S Zee, R John Leigh, Lance M Optican. Brain 2010
101
19

Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin.
Michaela Starck, Holger Albrecht, Walter Pöllmann, Marianne Dieterich, Andreas Straube. J Neurol 2010
41
19

A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.
L Averbuch-Heller, R J Tusa, L Fuhry, K G Rottach, G L Ganser, W Heide, U Büttner, R J Leigh. Ann Neurol 1997
136
19

Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Andreas Sprenger, Elisabeth Zils, Holger Rambold, Thurid Sander, Christoph Helmchen. Ann N Y Acad Sci 2005
21
19

4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
R Kalla, S Glasauer, F Schautzer, N Lehnen, U Büttner, M Strupp, T Brandt. Neurology 2004
55
19


4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation.
Roman Schniepp, Max Wuehr, Nibal Ackl, Adrian Danek, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2011
24
19

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
898
19

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, Anna Sulek, Alexandra Durr, Perrine Charles,[...]. Lancet Neurol 2013
113
19

Long-term effects of coordinative training in degenerative cerebellar disease.
Winfried Ilg, Doris Brötz, Susanne Burkard, Martin A Giese, Ludger Schöls, Matthis Synofzik. Mov Disord 2010
82
19

A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Jens Claassen, Rainer Spiegel, Roger Kalla, Mary Faldon, Christopher Kennard, Chotipat Danchaivijitr, Stanislaw Bardins, Nicole Rettinger, Erich Schneider, Thomas Brandt,[...]. J Neurol Neurosurg Psychiatry 2013
52
19

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
108
19

Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6.
Patrick Yu-Wai-Man, Grainne Gorman, David E Bateman, R John Leigh, Patrick F Chinnery. J Neurol 2009
22
14

Crossover trial of gabapentin and memantine as treatment for acquired nystagmus.
Matthew J Thurtell, Anand C Joshi, Alice C Leone, Robert L Tomsak, Gregory S Kosmorsky, John S Stahl, R John Leigh. Ann Neurol 2010
47
14

Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
Michael Strupp, Vera Carina Zingler, Viktor Arbusow, Daniel Niklas, Klaus Peter Maag, Marianne Dieterich, Sandra Bense, Diethilde Theil, Klaus Jahn, Thomas Brandt. N Engl J Med 2004
220
14

Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus.
K Hüfner, T Stephan, R Kalla, A Deutschländer, J Wagner, M Holtmannspötter, G Schulte-Altedorneburg, M Strupp, T Brandt, S Glasauer. Neurology 2007
40
14

Which medication do I need to manage dizzy patients?
Doreen Huppert, Michael Strupp, Harald Mückter, Thomas Brandt. Acta Otolaryngol 2011
21
14

Vestibular paroxysmia: diagnostic features and medical treatment.
K Hüfner, D Barresi, M Glaser, J Linn, C Adrion, U Mansmann, T Brandt, M Strupp. Neurology 2008
93
14

Episodic ataxia type 2.
Michael Strupp, Andreas Zwergal, Thomas Brandt. Neurotherapeutics 2007
98
14

Drug therapy for acquired pendular nystagmus in multiple sclerosis.
M Starck, H Albrecht, W Pöllmann, A Straube, M Dieterich. J Neurol 1997
89
14

Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin.
Rebecca McLean, Frank Proudlock, Shery Thomas, Chris Degg, Irene Gottlob. Ann Neurol 2007
77
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.